Julie K. Jadlowsky

California University of Pennsylvania — United States

Medicine · Health Sciences

19h-index3.7kcitations63works14.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(44), CRISPR and Genetic Engineering(19), Immune Cell Function and Interaction(14), HIV Research and Treatment(10), Virus-based gene therapy research(10)

Publications63 total

Cell-derived Nanoparticles Provide a Robust Platform to Manufacture Therapeutic T cells.
2026Open Access
Phase 1 study of autologous T cells bearing fully human chimeric antigen receptors targeting mesothelin in mesothelin-expressing cancers
Molecular Therapy·2026
Clinical trial results provide the rationale to protect dual HIV-specific T cells with a signaling-defective HIV fusion inhibitor
Molecular Therapy·2026
IL18-armored CAR T cells in relapsed/refractory B cell acute lymphoblastic leukemia
Blood·2025Open Access
CD19 CAR T cell therapy is an effective strategy for first CNS relapse in pediatric b ALL
Blood·2025Open Access
557 Evaluation of huCART19-IL18 manufactured using Synecta™ CDNP technology to improve CAR-T yield and consistency in cohort D of an ongoing phase I study (NCT04684563)
Regular and Young Investigator Award Abstracts·2025Open Access
CCR5-targeted allogeneic gamma–delta CD19 chimeric antigen receptor T cells for HIV-associated B cell-malignancy immunotherapy
Nature Biomedical Engineering·2025· 1 cited
Clinical and molecular dissection of CAR T cell resistance in pancreatic cancer
Cell Reports Medicine·2025· 2 citedOpen Access
Author Correction: Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial
Nature Medicine·2025· 3 citedOpen Access
Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial
Nature Medicine·2025· 38 citedOpen Access
Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure
New England Journal of Medicine·2025· 59 cited
CD22-targeted chimeric antigen receptor-modified T cells for children and adults with relapse of B-cell acute lymphoblastic leukemia after CD19-directed immunotherapy
Journal for ImmunoTherapy of Cancer·2025· 11 citedOpen Access
Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies
Nature Medicine·2025· 58 cited
TET2 regulates early and late transitions in exhausted CD8 <sup>+</sup> T cell differentiation and limits CAR T cell function
Science Advances·2024· 18 citedOpen Access
In Vivo Persistence and Function of CAR19 T-Cell Products for Pediatric B-Cell Acute Lymphoblastic Leukemia Are Impacted By Media, Cytokine Supplementation and Metabolite Bioavailability during Ex Vivo Manufacturing
Blood·2024· 1 citedOpen Access
237 Enhancing mesothelin-directed CAR T cell therapy for unresectable or metastatic pancreatic adenocarcinoma
Regular and Young Investigator Award Abstracts·2024· 1 citedOpen Access
Phase I clinical trial of autologous T cells bearing fully humanized chimeric antigen receptors targeting mesothelin with both intravenous administration and local delivery with or without lymphodepletion in mesothelin-expressing cancers, including ovarian cancer
Gynecologic Oncology·2024
Genotoxicity evaluation of gene therapies: A report from the International Workshop on Genotoxicity Testing (<scp>IWGT</scp>) 2022
Environmental and Molecular Mutagenesis·2024· 1 citedOpen Access
Data from Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors
2024Open Access
Supplementary Figure 1 from Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors
2024Open Access
page 1 of 4Next →

Frequent Co-authors

Joseph A. Fraietta(31), Carl H. June(29), Gabriela Plesa(21), Vanessa Gonzalez(17), Bruce L. Levine(13), Anne Chew(13), Megan M. Davis(12), Wei‐Ting Hwang(11), Elizabeth O. Hexner(10), Simon F. Lacey(10), Don L. Siegel(10), James L. Riley(9), In-Young Jung(8), J. Joseph Melenhorst(8), January Salas-McKee(8), Caitlin R. Hopkins(8), Irina Kulikovskaya(7), Donald L. Siegel(7), Julie S. Barber-Rotenberg(7), Sangya Agarwal(7)